Navigation Links
Positive Results From Avanafil Post-Prostatectomy Study Featured at Cancer Survivorship Meeting
Date:6/17/2011

expects to file the NDA for avanafil in the second quarter of 2011.

About AvanafilAvanafil is an investigational oral medication being developed for the treatment of erectile dysfunction.  Avanafil is a highly selective phosphodiesterase type 5 (PDE5) inhibitor licensed from Mitsubishi Tanabe Pharma Corporation. With the exception of certain Asian Pacific Rim countries, VIVUS owns worldwide development and commercial rights to avanafil for the treatment of sexual dysfunction.

About VIVUS VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company's lead investigational product in clinical development, QNEXA®, has completed phase 3 clinical trials for the treatment of obesity and is currently being considered for approval by U.S. and EU regulators. VIVUS received a Complete Response Letter, or CRL, to the initial QNEXA NDA on October 28, 2010. QNEXA is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. In the area of sexual health, VIVUS has completed phase 3 development with avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction. For more information about the company, please visit www.vivus.com.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "estimate," "expect," "forecast" and "intend," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, the timing and substance of our response to the FDA's requests from the QNEXA End-of-Review meeting; our response to, and continued dialogue with, the F
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Neurelis Announces Positive Results from Phase 1 Pharmacokinetic Study of NRL-01 (intranasal diazepam)
2. Dong-A PharmTech Co., Ltd. and Dr. Falk Pharma GmbH Announce Positive Data in Portal Hypertension With Udenafil
3. BioSpecifics Announces Positive XIAPEX® Data Presented at XVI Annual Federation of European Societies for Surgery of the Hand Congress
4. Tigris Pharmaceuticals Initiates Randomized Phase 2 Study of AFP-464 in ER-Positive Breast Cancer Patients
5. Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC
6. Sinovac Reports Positive Phase I Clinical Trial Results for EV71 Vaccine Candidate Against Hand, Foot & Mouth Disease(HFMD)
7. KemPharm, Inc. Announces Positive Results from Phase 1 Trial of KP201 for Pain
8. Amgen Receives CHMP Positive Opinion for XGEVA™ (Denosumab) in the European Union
9. Positive Results from Long-Term Phase 3 Study of Avanafil Featured at American Urological Association Annual Meeting
10. Positive Results Reported for Phase II Randomized Double-Blind Clinical Trial for the Treatment of Drug-Resistant Epilepsy Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
11. Reportlinker Adds Advanced Lung Cancer with EGFR Mutation Positive Adenocarcinoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... SAN DIEGO , Oct. 20, 2014 /PRNewswire/ ... the availability of the ResMed Data Exchange program, ... for home medical equipment (HME) and other health ... offers timely, secure access to critical patient information. ... from ResMed,s AirView™ and U-Sleep™ patient management platforms ...
(Date:10/20/2014)... 20, 2014  AnaptysBio, Inc., a leader in ... announced the appointment of Marco Londei , ... lead the preclinical and clinical development of AnaptysBio,s ... pleased to welcome Dr. Londei to AnaptysBio,s executive ... and Chief Executive Officer of AnaptysBio. "Dr. Londei,s ...
(Date:10/20/2014)... N.Y. , Oct. 20, 2014 Pharmaceutic ... outsourcing facility in Albany, NY ... trials. The company meets and/or exceeds the FDA standards ... and 21 CFR Part 211. The ... the highest levels of quality assurance and quality control. ...
Breaking Medicine Technology:ResMed Launches ResMed Data Exchange 2AnaptysBio Appoints Dr. Marco Londei to Newly Created Chief Development Officer Position Clinical Immunologist to Lead AnaptysBio's Pipeline Advancement 2
... As families gather for the holidays in the ... caregivers to make family health part of the ... one,s family health history, it,s also important to ... best ways to manage heath care expenses.   ...
... NEW YORK, Nov. 17, 2010 Reportlinker.com announces that ... catalogue: Global Pulse Oximeters Industry ... This report analyzes the worldwide markets for Pulse ... Types and End-Use Segments and covers non-invasive pulse oximeters ...
Cached Medicine Technology:CVS/pharmacy Helps Seniors Evaluate Medicare Part D Options and Identify Potential Ways to Save on Prescription Drugs in 2011 2Reportlinker Adds Global Pulse Oximeters Industry 2Reportlinker Adds Global Pulse Oximeters Industry 3Reportlinker Adds Global Pulse Oximeters Industry 4Reportlinker Adds Global Pulse Oximeters Industry 5Reportlinker Adds Global Pulse Oximeters Industry 6Reportlinker Adds Global Pulse Oximeters Industry 7Reportlinker Adds Global Pulse Oximeters Industry 8Reportlinker Adds Global Pulse Oximeters Industry 9Reportlinker Adds Global Pulse Oximeters Industry 10Reportlinker Adds Global Pulse Oximeters Industry 11Reportlinker Adds Global Pulse Oximeters Industry 12Reportlinker Adds Global Pulse Oximeters Industry 13Reportlinker Adds Global Pulse Oximeters Industry 14Reportlinker Adds Global Pulse Oximeters Industry 15Reportlinker Adds Global Pulse Oximeters Industry 16Reportlinker Adds Global Pulse Oximeters Industry 17Reportlinker Adds Global Pulse Oximeters Industry 18Reportlinker Adds Global Pulse Oximeters Industry 19Reportlinker Adds Global Pulse Oximeters Industry 20Reportlinker Adds Global Pulse Oximeters Industry 21Reportlinker Adds Global Pulse Oximeters Industry 22Reportlinker Adds Global Pulse Oximeters Industry 23Reportlinker Adds Global Pulse Oximeters Industry 24Reportlinker Adds Global Pulse Oximeters Industry 25Reportlinker Adds Global Pulse Oximeters Industry 26Reportlinker Adds Global Pulse Oximeters Industry 27
(Date:10/20/2014)... Zereana Jess-Huff, a 34-year-old mother, corporate executive and ... platform to think outside the bra. She doesn’t try to ... raise awareness about women’s other lady parts. , "We have ... the color pink and everybody knows what you’re talking about,” ... it has not been won when it comes to gynecologic ...
(Date:10/20/2014)... CA (PRWEB) October 20, 2014 AttorneyOne.com, a ... the latest information from the FDA on Sit and ... October 10 not to purchase or use Sit and Slim ... and Slim II is promoted as weight loss product on ... removed from the market in 2010 for safety reasons, can ...
(Date:10/20/2014)... CO (PRWEB) October 20, 2014 ... assays are the only imaging assays capable of ... a single test.  With these three dimensions of ... ability to detect the widest range of disease-causing ... usually missed by other genomic tools, including today’s ...
(Date:10/20/2014)... 20, 2014 It’s hard to imagine what ... and vulnerable children around the world, it’s a reality. And ... many children are forced to walk barefoot on rocky terrain ... or play with their friends. , Buckner International's ... Air1 Radio in October to encourage support for Air1 ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 Hastings and ... 30 years of service throughout the greater Phoenix area ... legal representation with regard to catastrophic automobile accidents. Statistics ... the country and throughout Arizona. As such, Hastings and ... for legal representation for those who have been injured ...
Breaking Medicine News(10 mins):Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 2Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 3
... Doubeni, M.D., M.P.H. of the University of Massachusetts Medical ... MA, researchers from// the National Cancer Institute-funded Cancer Research ... of death by race in colorectal cancer and factors ... persons. ,According to the study, African-Americans with ...
... confirmed outbreak of the deadly H5N1 virus in over a ... Mekong// Delta. ,Chickens and ducks were slaughtered in ... after tests on 2,000 poultry that had died earlier tested ... have begun to cull poultry in and around the infected ...
... new study published in the January issue of the medical ... protection for soldiers to// prevent permanent long-term hearing loss that ... ,The study measured the impact of “impulse ... no history of hearing disorders by using short-term exposure to ...
... by increasing Vitamin D levels in blood many cases of ... one of the most common neurological diseases affecting around two ... disease caused by attacking of the myelin sheath (the covering ... ,Previous researches have shown that vitamin D supplements ...
... married woman gets stress-relief by just holding her husband’s hand, ... who are worried that the institution of marriage// is losing ... a neuroscientist at the University of Virginia, finds that women ... holding their husband's hand and this has been observed in ...
... obstinate, as scientists have discovered, as they portray a ... extremely// difficult to annihilate. In fact radiation could even ... from the University of California, Los Angeles, who are ... cells that get radiation resistant and render breast cancer ...
Cached Medicine News:Health News:Colorectal Cancer Survival Rates Poorer in African-Americans 2Health News:Increase Vitamin D In Blood, Decrease Risk For Multiple Sclerosis 2
Coronary angiographic catheter...
... Merit has a complete offering of cardiology ... brands, these catheters are designed with excellent ... strength and better push-ability, and large inner ... 4, 5, 6 and 7 French sizes ...
The CRW system epitomizes simplicity, quality assurance, and versatility....
Hydrosteer wires are intended for use in the percutaneous introduction of catheters....
Medicine Products: